tumor suppressor genes
Showing 1 - 25 of >10,000
MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC
Not yet recruiting
- Lung Neoplasms
- +2 more
- Tumor samples
-
Bordeaux, FranceCHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023
Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)
Recruiting
- Neoplasms
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Prostate Cancer Recurrent Trial in Lexington (Hydroxychloroquine Sulfate 200Mg Tab)
Recruiting
- Prostate Cancer Recurrent
- Hydroxychloroquine Sulfate 200Mg Tab
-
Lexington, KentuckyMarkey Cancer Center - University of Kentucky
Jul 6, 2021
Cervical Intraepithelial Neoplasia Grade 2, DNA Methylation Trial in Maribor (Testing DNA methylation test for predicting
Recruiting
- Cervical Intraepithelial Neoplasia Grade 2
- DNA Methylation
- Testing DNA methylation test for predicting prognosis of untreated CIN 2
-
Maribor, SloveniaUniversity Medical Centre Maribor
Nov 14, 2022
Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)
Not yet recruiting
- Metastatic Solid Tumor
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 12, 2023
Breast Cancer, Bladder Cancer, Kidney Cancer Trial in New York (PCR/PCR/LDR Strategy)
Recruiting
- Breast Cancer
- +6 more
- PCR/PCR/LDR Strategy
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 1, 2022
Tumors, Solid Tumors Trial run by the NCI (TdCyd)
Suspended
- Neoplasms
- Solid Tumors
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 6, 2022
p53 Gene in Metabolism Regulation in Li-Fraumeni Syndrome
Completed
- Mitochondrial Disorders
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 18, 2021
Tumor Molecular Profiling in Patients With Prostate Cancer
Completed
- Prostate Cancer
- Metastatic Prostate Adenocarcinoma
- Tumor molecular profiling
-
Athens, GreeceHellenic Cooperative Oncology Group
Oct 17, 2022
NTRK Gene Fusion - Positive Advanced or Recurrent Solid
Recruiting
- Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Multiple Locations, JapanMany locations
Jan 20, 2023
Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation
Not yet recruiting
- Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation Sequencing (NGS) Panel (>30 Genes)
- Minimal documentation
- Extended documentation
-
Mannheim, Baden-Württemberg, Germany
- +1 more
Jan 18, 2023
Tumors Trial run by the National Cancer Institute (NCI) (FdCyd + THU)
Completed
- Neoplasms
- FdCyd + THU
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)
Recruiting
- Recurrent IDH1/2 Mutated Glioma
-
Paris, FrancePitie Salpetriere Hospital
Aug 29, 2022
Early Breast Cancer Three Years of More Post Primary Treatment
Recruiting
- Breast Cancer
- Exercise Recall Patient Reported Outcomes
- +10 more
-
Chapel Hill, North CarolinaUniversity of North Carolina
Jun 21, 2023
Advanced Solid Tumor Trial in Chengdu (KL590586 Capsule)
Enrolling by invitation
- Advanced Solid Tumor
- KL590586 Capsule
-
Chengdu, Sichuan, ChinaSichuan Kelun Botai Biopharmaceutical Co.
Feb 23, 2022
Genes in the Necessity of Secondary TURBT
Recruiting
- Bladder Cancer
-
Nanjing, Jiangsu, ChinaThe first affiliated hospital of Nanjing Medical University
Oct 27, 2021
Gallbladder Cancer Trial in Varanasi (Next generation sequencing)
Recruiting
- Gallbladder Cancer
- Next generation sequencing
-
Varanasi, UP, IndiaBanaras Hindu University
Jun 2, 2022
Bladder Cancer Trial in Mansoura (procedure, diagnostic test, genetic)
Completed
- Bladder Cancer
- Cystoscopy
- +3 more
-
Mansoura, DK, EgyptMansoura Urology and Nephrology Center
Apr 30, 2022
HBOC Syndrome, DNA Damage, Nutrition Therapy Trial in Mexico City (Antioxidant therapy)
Active, not recruiting
- HBOC Syndrome
- +2 more
- Antioxidant therapy
-
Mexico City, Benito Juárez, MexicoMaría Fernanda Díaz Yáñez
Mar 23, 2022
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
Not yet recruiting
- Myeloproliferative Neoplasms (MPNs)
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
- (no location specified)
Mar 24, 2023
Newer Therapeutic Targets in Head and Neck Cancers
Recruiting
- Head Neck Cancer
- Oral Cancer
- Next generation Sequencing
-
Varanasi, UP, IndiaBanaras Hindu University
May 19, 2022
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- Acute Lymphoblastic Leukemia
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
Pancreas Cyst Trial in Mannheim (Next Generation Sequencing, CEA and lipase, Cytology)
Completed
- Pancreas Cyst
- Next Generation Sequencing
- +3 more
-
Mannheim, GermanyTertiary referral hospital: Theresienkrankenhaus und St. Hedwig
Dec 17, 2022
Pathogenic Variants in Homologous Recombination Repair Genes in
Completed
- Epithelial Ovarian Cancer
- Tumor molecular profiling
- (no location specified)
Jan 18, 2021